Medical Therapy. Efficacy or Lack of Efficacy

Assessment of the effect of two regimens of milrinone infusion in paediatric patients with pulmonary artery hypertension undergoing corrective cardiac procedure: A prospective observational study

Mrugesh Prajapati, Jigar Patel, Hasmukh Patel, Hemang Gandhi, Guriqbal Singh, Pravin PatelU.N. Mehta Institute of Cardiology and Research CenterIndia Annals of Pediatric CardiologyAnn Pediatr Cardiol 2022; 15: 358-363DOI: 10.4103/apc.apc_230_21 AbstractBackground: The aim of the study was to compare the effect of two different regimens of milrinone in pediatric patients with pulmonary artery hypertension (PAH) undergoing corrective procedure.Materials […]

Assessment of the effect of two regimens of milrinone infusion in paediatric patients with pulmonary artery hypertension undergoing corrective cardiac procedure: A prospective observational study Read More »

Treprostinil in Neonates with Congenital Diaphragmatic Hernia-Related Pulmonary Hypertension

Felix R. De Bie, Catherine M. Avitabile, Sabrina Flohr, Sierra Land, Leny Mathew, Yan Wang, Devon Ash, Natalie E. Rintoul, Holly L. HedrickChildren’s Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine. Cluster Woman and Child. United States and Belgium Journal of PediatricsJ Pediatr 2023; DOI: 10.1016/j.jpeds.2023.113420 AbstractObjective: To describe our experience with treprostinil, evaluate

Treprostinil in Neonates with Congenital Diaphragmatic Hernia-Related Pulmonary Hypertension Read More »

Sildenafil Improves Pulmonary Vascular Remodeling in a Rat Model of Persistent Pulmonary Hypertension of the Newborn

Lili Kang, Xianghong Liu, Zilong Li, Xiao Mei Li, Yujie Han, Chen Liu, Cuifen Zhao, Xiaoying LiQilu Children’s Hospital of ShanDong University. Qilu Hospital and Cheeloo College of MedicineChina Journal of Cardiovascular PharmacologyJ Cardiovasc Pharmacol 2023; 81: 232-239DOI: 10.1097/FJC.0000000000001373 AbstractPersistent pulmonary hypertension of the newborn (PPHN) is characterized by pulmonary arterial remodeling mainly because of apoptosis

Sildenafil Improves Pulmonary Vascular Remodeling in a Rat Model of Persistent Pulmonary Hypertension of the Newborn Read More »

Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide

Yi Guan, Ya Jin, Yongxue Lu, Dang Ao, Pingjiao Gu, Jiyan Yang, Guosheng Liu, Shasha HanThe First Affiliated Hospital of Jinan University. The First People’s Hospital of Foshan. The Affiliated Hospital of Guangdong Medical University. Foshan Women and Children Hospital. Guangdong Women and Children Hospital. China BioMed Central Pregnancy and ChildbirthBMC Pregnancy Childbirth 2023; 23:

Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide Read More »

Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension

Lukas Schroeder, Stanley Holcher, Judith Leyens, Annegret Geipel, Brigitte Strizek, Till Dresbach, Andreas Mueller, Florian KipfmuellerUniversity Children’s Hospital Bonn. University Hospital Bonn.Germany European Journal of PediatricsEur J Pediatr 2023; DOI: 10.1007/s00431-023-04971-9 AbstractLevosimendan as a calcium-sensitizer is a promising innovative therapeutical option for the treatment of severe cardiac dysfunction (CD) and pulmonary hypertension (PH) in preterm infants,

Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension Read More »

Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network meta-analysis

Fen Cao, Kun Wu, Yongzhi Zhu, Junjun Jiang, Gui Zhang, Jun Liu, Ping Xiao, Yang Tian, Wei Zhang, Sheng Zhang, Feng Hou, Zhongwu BaoHuaihua First People’s Hospital.China Frontiers in Cardiovascular MedicineFront Cardiovasc Med 2023; 9: DOI: 10.3389/fcvm.2022.1055897 AbstractBackground: Pulmonary arterial hypertension (PAH) is a fatal disease characterized by pulmonary vascular remodeling and increased pulmonary artery pressure, leading

Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network meta-analysis Read More »

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration

Jenna M. Faircloth, Neelam D. Bhatt, Corey A. Chartan, Ryan D. Coleman, Natalie Villafranco, Fadel E. Ruiz, Raysa Morales-Demori, Elise Whalen, Erin Ely, Rozmeen Fombin, Nidhy P. VargheseTexas Children’s Hospital and Baylor College of Medicine.United States Frontiers in PediatricsFront Pediatr 2023; 11: DOI: 10.3389/fped.2023.1050508 AbstractSelexipag, a selective prostacyclin receptor agonist, is approved for treating pulmonary arterial

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration Read More »

Paediatric acute respiratory distress syndrome: consider the role of lymphatics

Mimi Lu, Elena Cavazzoni, Hiran Selvadurai, Juerg Martin BurrenChildren’s Hospital at Westmead. University of Sydney Discipline of Child and Adolescent Health. Australia British Medical Journal Case ReportsBMJ Case Rep 2022; 15: DOI: 10.1136/bcr-2021-245543 AbstractWe present a case of a 7-day-old male infant with severe respiratory disease requiring venoarterial extracorporeal membrane oxygenation therapy with evidence of lymphangiectasia

Paediatric acute respiratory distress syndrome: consider the role of lymphatics Read More »

Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions

Shreva Agarwal, Berkley Kingman Anderson, Priya Mahajan, Caraciolo J. Fernandes, Judith F. Margolin, Ionela IacobasTexas Children’s Hospital and Baylor College of Medicine.United States Pediatric Blood and CancerPediatr Blood Cancer 2022; 69: DOI: 10.1002/pbc.29510 AbstractBackground: Chylothorax can be a presenting symptom of complex lymphatic anomaly in children and is associated with significant respiratory morbidity. Historically, the traditional pharmacological

Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions Read More »

Successfully Reducing Fat-modified Diet Duration for Treating Postoperative Chylothorax in Children

Melissa M. Winder, Senthuran Vijayarajah, Ron W. Reeder, Emilee T. Glenn, Rohin Moza, Aaron W. Eckhauser, David K. BaillyUniversity of Utah and Primary Children’s Hospital.United States Annals of Thoracic SurgeryAnn Thorac Surg 2022; 114: 2363-2371DOI: 10.1016/j.athoracsur.2021.10.028 AbstractBackground: Medical management, primarily a fat-modified diet (FMD), is the mainstay of treatment for most patients with chylothorax. Duration of FMD

Successfully Reducing Fat-modified Diet Duration for Treating Postoperative Chylothorax in Children Read More »

Scroll to Top